Lung Cancer Nexus
Congresses
Stay ahead on key advances in non–small-cell lung cancer (NSCLC) and small-cell lung cancer (SCLC), with updates from the major oncology congresses. Browse articles and expert videos to support interpretation of the latest evidence and evolving treatment strategies.
ASCO 2026: CROWN study. Lorlatinib in ALK+ NSCLC
Explore 7-year CROWN data from ASCO 2026 showing durable lorlatinib benefit in ALK+ NSCLC, including long-term CNS control and safety outcomes.
Updates in your area
of interest
of interest
Articles your peers
are looking at
are looking at
Bookmarks
saved
saved
Days to your
next event
next event